VolitionRX Q3 EPS $(0.05) Misses $(0.04) Estimate, Sales $627.277K Miss $1.681M Estimate

VolitionRX (AMEX: VNRX) reported quarterly losses of $(0.05) per share which missed the analyst consensus estimate of $(0.04) by 13.64 percent. This is a 28.57 percent increase over losses of $(0.07) per share from the same period last year. The company reported quarterly sales of $627.277 thousand which missed the analyst consensus estimate of $1.681 million by 62.68 percent. This is a 32.19 percent increase over sales of $474.522 thousand the same period last year.